telmisartan has been researched along with Cognitive Decline in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfuraih, BS; Alsuhaibani, NA; Elsayed, AM; Mahmoud, RH; Nadwa, EH; Rashed, LA; Said, ES | 1 |
| Cao, HM; Deng, Y; Duan, R; Fu, XX; Jiang, T; Lian, HW; Wei, B; Zhang, YD | 1 |
| Abd El-Latif, AM; Abdelkader, NF; Khattab, MM | 1 |
| Abo-Youssef, AMH; El-Sayed, NS; Khallaf, WAI; Messiha, BAS | 1 |
| Chai, Q; Chen, Y; Cui, Y; Dong, Y; Duan, D; Gong, G; Hu, W; Ji, T; Liu, Z; Sheng, L; Sun, S; Wang, J; Zhang, H; Zhao, Y; Zhou, T | 1 |
1 trial(s) available for telmisartan and Cognitive Decline
| Article | Year |
|---|---|
Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Cognitive Dysfunction; Disease Progression; Double-Blind Method; Essential Hypertension; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukoencephalopathies; Male; Middle Aged; Rosuvastatin Calcium; Telmisartan | 2019 |
4 other study(ies) available for telmisartan and Cognitive Decline
| Article | Year |
|---|---|
Evaluation of nootropic activity of telmisartan and metformin on diazepam-induced cognitive dysfunction in mice through AMPK pathway and amelioration of hippocampal morphological alterations.
Topics: AMP-Activated Protein Kinases; Animals; Behavior, Animal; Caspase 3; Cell Death; Cognitive Dysfunction; Diazepam; Disease Models, Animal; Hippocampus; Maze Learning; Metformin; Mice; Neuroprotective Agents; NF-kappa B; Nootropic Agents; Piracetam; Signal Transduction; Telmisartan; Tumor Necrosis Factor-alpha | 2021 |
Telmisartan Alleviates Alzheimer's Disease-Related Neuropathologies and Cognitive Impairments.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents; Cognitive Dysfunction; Disease Models, Animal; Mice; Mice, Transgenic; Neuroinflammatory Diseases; Telmisartan | 2023 |
Telmisartan/17β-estradiol mitigated cognitive deficit in an ovariectomized rat model of Alzheimer's disease: Modulation of ACE1/ACE2 and AT1/AT2 ratio.
Topics: Alzheimer Disease; Animals; Blotting, Western; Cognitive Dysfunction; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Estradiol; Female; Hippocampus; Maze Learning; Nootropic Agents; Ovariectomy; Rats; Rats, Wistar; Renin-Angiotensin System; Telmisartan | 2020 |
Protective effects of telmisartan and tempol on lipopolysaccharide-induced cognitive impairment, neuroinflammation, and amyloidogenesis: possible role of brain-derived neurotrophic factor.
Topics: Amyloid; Animals; Benzimidazoles; Benzoates; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Cyclic N-Oxides; Cytoprotection; Inflammation; Lipopolysaccharides; Male; Mice; Oxidative Stress; Spin Labels; Telmisartan | 2017 |